Denagliptin tosilate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDenagliptin tosilate
Drug Alias NameDenagliptina地格列汀迪那格列汀DenagliptinumGW-823093 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[12] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSmithkline Beecham Plc (Trading As T/A Smithkline Beecham Pharmaceuticals)Glaxosmithkline PlcSmithkline Beecham Plc +[4] 
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksKEGG